AdvisorShares Psychedelics ETF (PSIL)
- Expense ratio1.01%
- Net assets$44.6M
- Dividend yield7.73%
- 1-year return+9.29%
- Holdings26
PSIL ETF price chart
PSIL quote & trading statistics
PSIL performance
Total return · as of October 17, 2026- YTD+19.66%
- 1 year+9.29%
- 3 years+14.97%/yr
- 5 years-23.72%/yr
- 10 years0.00%/yr
- 1Y volatility
- 23.84%
- 3Y volatility
- 47.13%
- 3Y Sharpe ratio
- 0.47
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
PSIL top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics, Inc. | 11.02% |
| 2 | CMPS | Compass Pathways Plc | 10.71% |
| 3 | HELP | Helus Pharma Inc. | 9.19% |
| 4 | LLY | Eli Lilly and Company | 5.94% |
| 5 | ABBV | AbbVie Inc | 5.63% |
| 6 | NBIX | Neurocrine Biosciences Inc | 4.98% |
| 7 | JNJ | Johnson & Johnson | 4.87% |
| 8 | NRXP | NRX Pharmaceuticals Inc | 4.54% |
| 9 | DRUG | Bright Minds Biosciences Inc | 4.42% |
| 10 | RLMD | Relmada Therapeutics Inc | 4.25% |
The top 10 holdings make up 65.6% of the fund (26 holdings in total). As of October 17, 2026.
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
PSIL ETF FAQ
What is the PSIL expense ratio?
AdvisorShares Psychedelics ETF has a net expense ratio of 1.01%, or $101.00 a year for every $10,000 invested.
How much money is in PSIL?
AdvisorShares Psychedelics ETF has about $44.6M in net assets.
What are the top holdings of PSIL?
The largest positions in PSIL are Definium Therapeutics, Inc. (11.02%), Compass Pathways Plc (10.71%), Helus Pharma Inc. (9.19%). The fund holds 26 securities in total.
How has PSIL performed?
PSIL returned +9.29% over the past year and -23.72% a year over the past five years, including reinvested distributions.
Does PSIL pay dividends?
PSIL has a dividend yield of 7.73%.
When was PSIL launched?
AdvisorShares Psychedelics ETF began trading on September 15, 2021.